Roundup

Features

February’s top news stories

Eidos Therapeutics starts Phase III trial of AG10 in ATTR-CM Eidos Therapeutics commenced a pivotal Phase III clinical trial of…

Features

January’s top news stories

Janssen unblinds Phase III TITAN study for prostate cancer Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III…

Features

2018: The year’s biggest Drug Development Technology stories

NIH to assess efficacy of male contraceptive skin gel The US National Institutes of Health (NIH) has provided funding for…